ÐÒÔË·Éͧ¼Æ»®

Home
Bergen Gynecologic Cancer Research Group

Doctoral theses

Completed doctoral theses by year (links in Norwegian).

Main content

ÌýÌý


2024
Ìý
Kari S. Wagner-Larsen

Advanced MRI for developing more personalized treatment strategies in uterine cervical cancer

Hilde E. Lien

Single cell expression patterns in endometrial cancer and novel biomarkers for improved treatment


2023
Ìý
Kristine E. FasmerMRI and 2-[18F]FDG PET/CT for staging, prognostication, and tailoring treatment in endometrial cancer.

Ìý

2022

Ìý
Hege F. BergOrganoid models and novel biomarkers for improved treatment of endometrial cancer.Ìý

Ìý

2021

Ìý

David E. Forsse

Novel preoperative biomarkers and evaluation of altered treatment strategies to improve outcome for endometrial cancer patients.

Ìý

2020

Ìý
Hilde R. EngerudMolecular markers to predict prognosis and guide therapy in endometrial cancer

Ìý

2019

Ìý
Sigmund Ytre-HaugeAdvanced imaging biomarkers in endometrial cancer

Ìý

2018

Ìý
Tina FonnesPreclinical models and molecular biomarkers – tools to improve treatment in endometrial carcinoma

Ìý

2017

Ìý
Anna BergMolecular alterations and diagnostic imaging in premalignant and malignant endometrial lesions for improved diagnosis and treatment
Karen K. MaulandContext-related biomarkers in endometrial cancer – a study with focus on obesity and genomic alterations
Mari K. HalleMolecular alterations suggesting new treatment strategies in uterine carcinomas

Ìý

2013

Ìý
Endometrial carcinoma: a step closer to individualized therapy? Exploring transcriptional alterations in relation to prognostic biomarkers
Mutations and gene amplifications in Endometrial Carcinomas. “Clinical characteristics and potential targets for therapyrelated to KRAS, MYC, ATAD2, PIK3CA and FGFR2 alterations

Ìý

2012

Ìý
Endometrial cancer; can biomarkers aid in the prediction of aggressive disease? A study with focus on preoperative tumour markers

Ìý